Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women's risk of HIV?

Polis, C. B., Achilles, S. L., Hel, Z., & Hapgood, J. P. (2018, March 1). Is a lower-dose, subcutaneous contraceptive injectable containing depot medroxyprogesterone acetate likely to impact women’s risk of HIV? Contraception. Elsevier USA. https://doi.org/10.1016/j.contraception.2017.12.003